Loading…
AngioDynamics, Inc. is projected to rise to $22.51 by 2027, a +52% move from its current price of $14.79. ANGO is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/1/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 2 | $14.45 | $14.81 | $15.18 | +0.13% |
| Aug 3 | $14.32 | $14.83 | $15.35 | +0.27% |
| Aug 4 | $14.23 | $14.85 | $15.49 | +0.40% |
| Aug 5 | $14.16 | $14.87 | $15.62 | +0.54% |
| Aug 6 | $14.09 | $14.89 | $15.73 | +0.67% |
| Aug 7 | $14.04 | $14.91 | $15.83 | +0.80% |
| Aug 8 | $13.99 | $14.93 | $15.93 | +0.94% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $13.99 | $14.93 | $15.93 | +0.94% |
| Week 2 | $13.75 | $15.07 | $16.52 | +1.89% |
| Week 3 | $13.59 | $15.21 | $17.02 | +2.85% |
| Week 4 | $13.49 | $15.35 | $17.48 | +3.81% |
| Week 5 | $13.41 | $15.50 | $17.92 | +4.79% |
| Week 6 | $13.35 | $15.64 | $18.34 | +5.77% |
| Week 7 | $13.30 | $15.79 | $18.75 | +6.77% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
AngioDynamics, Inc. is a medical technology company that designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments and offers a broad portfolio, including the Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium, along with AlphaVac mechanical thrombectomy system and thrombolytic catheters used to dissolve blood clots.
Its AngioVac venous drainage cannula and extracorporeal circuit support procedures for up to six hours, and the NanoKnife IRE Ablation System provides a non-thermal option for soft-tissue ablation. The portfolio also includes peripheral products such as angiographic catheters, guidewires, drainage catheters, and micropuncture kits, as well as other endovascular and interventional tools. AngioDynamics was founded in 1988 and is headquartered in Latham, New York.
AngioDynamics, Inc. is a healthcare company in the medical technology sector with a broad vascular and interventional portfolio. The stock is currently priced around $14.63 with a market capitalization of $604.69M, and it holds a rank of 2877 by market capitalization.
The near-term price outlook aligns with a 2026 average price of $14.63, which implies a flat-to-marginally changing path in the immediate horizon.
A major floor 34.4% below — a decisive break under it would weaken the trend.
The nearest floor, 17.8% below — buyers have tended to step in here.
Price is pressing into resistance (0.0% away) — a breakout level to watch.
A major ceiling 11.9% above — clearing it would confirm fresh momentum.
Key ANGO support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ANGO market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $14.44 | Buy | $14.49 | Buy |
| MA 10 | $14.10 | Buy | $14.19 | Buy |
| MA 20 | $13.67 | Buy | $13.78 | Buy |
| MA 50 | $12.78 | Buy | $12.96 | Buy |
| MA 100 | $11.78 | Buy | $12.28 | Buy |
| MA 200 | $11.78 | Buy | $11.66 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 66.52 | Neutral |
| Stoch RSI (14) | 62.91 | Neutral |
| CCI (20) | 127.58 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.07 | Buy |
| ROC (12) | 2.21 | Buy |
| Bollinger %B (20,2) | 0.91 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.49 | Buy |
| Awesome (5,34) | 1.18 | Buy |
| Ultimate (7,14,28) | 73.33 | Sell |
| Momentum (10) | 1.28 | Buy |
| Aroon Osc (25) | 56.00 | Buy |
| Hull MA (9) | 14.93 | Sell |
| ADX (14) | 22.47 | Buy |
| ATR (14) | 0.29 | Info |
The 30-day technical picture shows bullish momentum with RSI14 at 70. The stock is trading above the SMA50 of $12.64 and above the SMA200 of $11.74, which signals a positive trend. Support is at $11.74 and resistance at $14.63, with a 30-day price range from $12.32 to $17.37, indicating room for movement within a defined band.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $9.70 | $14.79 | $21.28 | 0% | Neutral | |
| $18.12 | $22.51 | $29.46 | +52% | Bullish | |
| $22.85 | $29.11 | $39.42 | +97% | Bullish | |
| $26.60 | $34.60 | $48.12 | +134% | Bullish | |
| $29.94 | $39.65 | $56.41 | +168% | Bullish | |
| $33.44 | $45.02 | $65.31 | +204% | Bullish | |
| $35.31 | $48.27 | $71.27 | +226% | Bullish | |
| $43.39 | $60.17 | $90.27 | +307% | Bullish | |
| $54.60 | $76.74 | $116.84 | +419% | Bullish | |
| $58.77 | $83.69 | $129.17 | +466% | Bullish | |
| $87.78 | $132.51 | $216.58 | +796% | Bullish | |
| $200.79 | $334.71 | $594.92 | +21.6x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $9.70 | $14.79 | $17.88 | +0.00% |
| September 2026 | $13.36 | $15.76 | $19.08 | +6.53% |
| October 2026 | $14.08 | $16.71 | $20.43 | +6.04% |
| November 2026 | $14.19 | $16.92 | $20.85 | +1.27% |
| December 2026 | $14.31 | $17.15 | $21.28 | +1.37% |
Click any year to see its month-by-month ANGO forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
AngioDynamics, Inc.'s 2026 outlook centres on $14.79, within a $9.70 to $21.28 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, ANGO could reach as high as $29.46, with a base case around $22.51 and support toward $18.12 — roughly +52% from $14.79. Buyers look set to stay in control over this stretch.
Expect ANGO to range from $22.85 to $39.42 through 2028. The $29.11 average target implies a +97% move from current prices. That is up +29% on the projected 2027 average. Momentum favours further upside here.
The ANGO price prediction for 2029 points to an average of $34.60 (low $26.60, high $48.12) — a potential gain of +134% on today's $14.79. Buyers look set to stay in control over this stretch.
In 2030, ANGO is projected to trade between $29.94 and $56.41, averaging $39.65 — a potential gain of +168% from today's $14.79. That is up +15% on the projected 2029 average. Momentum favours further upside here.
AngioDynamics, Inc.'s 2031 outlook centres on $45.02, within a $33.44 to $65.31 range. That is up +14% on the projected 2030 average. That marks a +204% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, ANGO could reach as high as $71.27, with a base case around $48.27 and support toward $35.31 — roughly +226% from $14.79. Momentum favours further upside here.
Expect ANGO to range from $43.39 to $90.27 through 2033. The $60.17 average target implies a +307% move from current prices. That is up +25% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The ANGO price prediction for 2034 points to an average of $76.74 (low $54.60, high $116.84) — a potential gain of +419% on today's $14.79. Momentum favours further upside here.
In 2035, ANGO is projected to trade between $58.77 and $129.17, averaging $83.69 — a potential gain of +466% from today's $14.79. That is up +9% on the projected 2034 average. Buyers look set to stay in control over this stretch.
AngioDynamics, Inc.'s 2040 outlook centres on $132.51, within a $87.78 to $216.58 range. That is up +58% on the projected 2035 average. That marks a +796% change versus current levels. Momentum favours further upside here.
By 2050, ANGO could reach as high as $594.92, with a base case around $334.71 and support toward $200.79 — roughly +21.6x from $14.79. Buyers look set to stay in control over this stretch.
Investing $1,000 in ANGO today (≈ 67.613252 ANGO) could be worth
$22,631.03
+$21,631.03 (+2163%) by 2050 · US Dollar
Based on the average projected ANGO price of $334.71 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ANGOwould be worth at today's price.
$1,000 invested in ANGO on Jul 31, 2025 (≈ 112.866822 ANGO) would be worth
$1,669.3
+$669.3 (+66.9%) today · 1.67× · US Dollar
Based on a ANGO entry price of $8.86 vs. today's $14.79.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $13.59 | $1,088.3 | +8.8% |
| 1 month ago | $13.08 | $1,130.73 | +13.1% |
| 3 months ago | $11.16 | $1,325.27 | +32.5% |
| 6 months ago | $10.42 | $1,419.39 | +41.9% |
| 1 year ago | $8.86 | $1,669.3 | +66.9% |
| All time (5.0y) ago | $26.97 | $548.39 | -45.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ANGO forecast.
Our base-case forecast reaches $30.00 around 2029.
Implied market cap at $30.00: $1.24B
The multi-year forecast maps a path of rising averages and strong upside. For 2026, the average price is $14.63 with a low of $9.70 and a high of $21.26 and a 0% ROI, indicating a neutral short-term stance. From 2027 onward, the average price climbs to $22.47 (ROI 53.6%), then to $29.04 in 2028 (ROI 98.5%), $34.60 in 2029 (ROI 136.5%), and $39.49 in 2030 (ROI 169.9%), with sentiment staying bullish.
The forecast continues to rise through 2031 ($44.57, ROI 204.7%), 2032 ($47.76, ROI 226.5%), 2033 ($59.80, ROI 308.7%), 2034 ($76.51, ROI 423%), and 2035 ($83.42, ROI 470.2%), followed by substantial gains in later years: 2040 ($131.11, ROI 796.1%) and 2050 ($333.76, ROI 2181.3%). These are forecasted estimates and not guarantees, reflecting modeled upside with ongoing bullish sentiment in the longer term.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $39.49, with a low of $29.54 and a high of $56.82, and a projected ROI of 169.9% with a bullish sentiment.
Forecasts from 2027 onward are bullish, with average prices rising from $22.47 in 2027 to higher levels and positive ROIs (e.g., 53.6% in 2027, 98.5% in 2028, 136.5% in 2029, and higher in subsequent years). The 2026 outlook is neutral with an average of $14.63 and ROI of 0%.
Yes. The forecast includes yearly maximums that exceed $100, with a max of $118.20 in 2034 and higher thereafter (e.g., $130.72 in 2035), indicating the potential to surpass $100 in the projection window.
Current price is $14.63. The 30-day range spans from $12.32 to $17.37.
RSI14 is 70, and the annualized volatility is 50%.
AngioDynamics, Inc. Community Discussion
0Share your AngioDynamics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.